FI106864B - Menetelmä terapeuttisesti käyttökelpoisten indolopyrrolokarbatsolijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten indolopyrrolokarbatsolijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI106864B
FI106864B FI925422A FI925422A FI106864B FI 106864 B FI106864 B FI 106864B FI 925422 A FI925422 A FI 925422A FI 925422 A FI925422 A FI 925422A FI 106864 B FI106864 B FI 106864B
Authority
FI
Finland
Prior art keywords
group
groups
formula
lower alkyl
compound
Prior art date
Application number
FI925422A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI925422A (fi
FI925422A0 (fi
Inventor
Hisao Kondo
Mitsuru Ohkubo
Hiroharu Arakawa
Katsuhisa Kojiri
Hiroyuki Suda
Original Assignee
Banyu Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd
Publication of FI925422A0 publication Critical patent/FI925422A0/fi
Publication of FI925422A publication Critical patent/FI925422A/fi
Application granted granted Critical
Publication of FI106864B publication Critical patent/FI106864B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/044—Pyrrole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Silicon Polymers (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI925422A 1991-11-29 1992-11-27 Menetelmä terapeuttisesti käyttökelpoisten indolopyrrolokarbatsolijohdannaisten valmistamiseksi FI106864B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP34191691 1991-11-29
JP34191691 1991-11-29
JP6926992 1992-02-18
JP6926992 1992-02-18
JP25730692 1992-09-01
JP25730692 1992-09-01

Publications (3)

Publication Number Publication Date
FI925422A0 FI925422A0 (fi) 1992-11-27
FI925422A FI925422A (fi) 1993-05-30
FI106864B true FI106864B (fi) 2001-04-30

Family

ID=27300000

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925422A FI106864B (fi) 1991-11-29 1992-11-27 Menetelmä terapeuttisesti käyttökelpoisten indolopyrrolokarbatsolijohdannaisten valmistamiseksi

Country Status (27)

Country Link
EP (1) EP0545195B1 (bg)
JP (1) JP2629542B2 (bg)
KR (1) KR100275976B1 (bg)
AT (1) ATE130617T1 (bg)
AU (1) AU650376B2 (bg)
BG (1) BG61036B1 (bg)
CA (1) CA2083534C (bg)
CZ (1) CZ287304B6 (bg)
DE (1) DE69206242T2 (bg)
DK (1) DK0545195T3 (bg)
DZ (1) DZ1634A1 (bg)
ES (1) ES2079774T3 (bg)
FI (1) FI106864B (bg)
GR (1) GR3018527T3 (bg)
HU (3) HU217611B (bg)
IL (1) IL103844A (bg)
MX (1) MX9206847A (bg)
MY (1) MY114655A (bg)
NO (1) NO178929C (bg)
NZ (1) NZ245203A (bg)
PL (1) PL171468B1 (bg)
RO (1) RO113469B1 (bg)
RU (1) RU2117671C1 (bg)
SA (1) SA93130351B1 (bg)
TW (1) TW224469B (bg)
WO (1) WO1993011145A1 (bg)
YU (1) YU48963B (bg)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995030682A1 (fr) * 1994-05-09 1995-11-16 Banyu Pharmaceutical Co., Ltd. Derive d'indolopyrolocarbazole antitumoral
PT760375E (pt) * 1994-05-09 2004-04-30 Banyu Pharma Co Ltd Derivado de indolopiprolocarbazole anti-tumoral
DE69531686T2 (de) * 1994-06-13 2004-07-15 Banyu Pharmaceutical Co., Ltd. Glycosyltransferase kodierendes gen und seine verwendung
AU3086495A (en) * 1994-08-02 1996-03-04 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazoles
US5594009A (en) * 1994-10-14 1997-01-14 Cephalon, Inc. Fused pyrrolocarbazoles
US5591855A (en) * 1994-10-14 1997-01-07 Cephalon, Inc. Fused pyrrolocarbazoles
US5475110A (en) * 1994-10-14 1995-12-12 Cephalon, Inc. Fused Pyrrolocarbazoles
US5705511A (en) * 1994-10-14 1998-01-06 Cephalon, Inc. Fused pyrrolocarbazoles
AU6836696A (en) * 1995-09-05 1997-03-27 Banyu Pharmaceutical Co., Ltd. Antitumor indolopyrrolocarbazole derivatives
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
DE69709407T2 (de) * 1996-08-22 2002-05-29 Bristol-Myers Squibb Co., Wallingford Zytotoxischer aminozucker und verwandte zuckerderivate von indolopyrrolocarbazolen
GB9811624D0 (en) * 1998-05-29 1998-07-29 Merck Sharp & Dohme Therapeutic use
US6013646A (en) * 1998-07-02 2000-01-11 Bayer Corporation Indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6703373B1 (en) 1999-09-10 2004-03-09 Banyu Pharmaceutical Co., Ltd. Indolopyrrolocarbazole derivatives and antitumor agents
FR2801054B1 (fr) * 1999-11-17 2003-06-13 Adir Nouveaux derives de 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo [3,4-c]carbazole et 12,13-(pyranosyl)-furo[3,4-c]indolo [2,3-a]carbazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6790836B2 (en) 2000-02-24 2004-09-14 Banyu Pharmaceutical Co., Ltd. Process for preparing indolopyrrolocarbazole derivatives, intermediates therefor, and preparation process of the intermediates
US6677450B2 (en) 2000-10-06 2004-01-13 Bristol-Myers Squibb Company Topoisomerase inhibitors
US6653290B2 (en) 2000-10-06 2003-11-25 Bristol-Myers Squibb Company Tumor proliferation inhibitors
US6610727B2 (en) 2000-10-06 2003-08-26 Bristol-Myers Squibb Company Anhydro sugar derivatives of indolocarbazoles
US6555677B2 (en) 2000-10-31 2003-04-29 Merck & Co., Inc. Phase transfer catalyzed glycosidation of an indolocarbazole
MXPA03008589A (es) 2001-03-22 2003-12-08 Bristol Myers Squibb Co Derivados de azucar citotoxicos selectivos de topoisomerasa i de indolopirrolocarbazoles.
US6559299B2 (en) 2001-03-29 2003-05-06 Merck & Co., Inc. Preparation and isolation of indolocarbazole glycosides
UA80552C2 (en) * 2002-03-26 2007-10-10 Combined drug of the antitumoral derivative indolopyrrolocarbazole and other antitumoral agent and its application at cancer treatment
CA2398828A1 (en) 2002-08-09 2004-02-09 Merck & Co., Inc. A pharmaceutical composition containing an indolopyrrolocarbazole derivative
WO2005010017A1 (ja) * 2003-07-24 2005-02-03 Banyu Pharmaceutical Co., Ltd インドロピロロカルバゾール誘導体及び抗腫瘍剤
JPWO2005026185A1 (ja) * 2003-09-16 2006-11-16 萬有製薬株式会社 抗腫瘍性新規インドロピロロカルバゾール誘導体
US7241779B2 (en) * 2003-12-23 2007-07-10 Cephalon, Inc. Fused pyrrolocarbazoles
US7169802B2 (en) 2003-12-23 2007-01-30 Cephalon, Inc. Fused pyrrolocarbazoles
ES2326459B1 (es) 2008-04-08 2010-05-28 Universidad De Oviedo Indolocarbazoles glicosilados, su procedimiento de obtencion y sus usos.
MX2011005055A (es) 2008-11-19 2011-05-31 Cephalon Inc Nuevas formas de un compuesto de indazolo [5,4-a]pirrolo[3,4-c]car bazol.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4785085A (en) * 1986-11-21 1988-11-15 Bristol-Myers Company Rebeccamycin analogs
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
CA2037596C (en) * 1990-03-06 1995-07-18 Kin Sing Lam Rebeccamycin analog by bromide precursor feeding
IL97233A (en) * 1990-03-06 1995-03-30 Bristol Myers Squibb Co Analogs of rabamycin, their manufacture and pharmaceutical preparations containing them

Also Published As

Publication number Publication date
YU48963B (sh) 2003-01-31
EP0545195A1 (en) 1993-06-09
DZ1634A1 (fr) 2002-02-17
DK0545195T3 (da) 1995-12-18
NO178929B (no) 1996-03-25
IL103844A0 (en) 1993-04-04
RU2117671C1 (ru) 1998-08-20
HU217611B (hu) 2000-03-28
CZ287304B6 (cs) 2000-10-11
CA2083534C (en) 2003-01-28
HU211254A9 (en) 1995-11-28
KR100275976B1 (ko) 2001-02-01
SA93130351B1 (ar) 2005-10-16
JP2629542B2 (ja) 1997-07-09
PL304729A1 (en) 1995-01-09
EP0545195B1 (en) 1995-11-22
JPH06128283A (ja) 1994-05-10
AU2963792A (en) 1993-06-03
NO178929C (no) 1996-07-03
HU9203754D0 (en) 1993-03-29
DE69206242D1 (de) 1996-01-04
BG61036B1 (bg) 1996-09-30
CZ350892A3 (en) 1993-10-13
GR3018527T3 (en) 1996-03-31
MY114655A (en) 2002-12-31
IL103844A (en) 1997-09-30
NZ245203A (en) 1997-07-27
WO1993011145A1 (en) 1993-06-10
FI925422A (fi) 1993-05-30
AU650376B2 (en) 1994-06-16
FI925422A0 (fi) 1992-11-27
ES2079774T3 (es) 1996-01-16
NO924593L (no) 1993-06-01
KR930010039A (ko) 1993-06-21
YU102692A (sh) 1996-02-19
TW224469B (bg) 1994-06-01
DE69206242T2 (de) 1996-03-28
HUT65699A (en) 1994-07-28
PL171468B1 (pl) 1997-05-30
BG97970A (bg) 1994-04-29
CA2083534A1 (en) 1993-05-30
NO924593D0 (no) 1992-11-27
RO113469B1 (ro) 1998-07-30
MX9206847A (es) 1993-06-30
ATE130617T1 (de) 1995-12-15

Similar Documents

Publication Publication Date Title
FI106864B (fi) Menetelmä terapeuttisesti käyttökelpoisten indolopyrrolokarbatsolijohdannaisten valmistamiseksi
AU2001273670B2 (en) Pyrido(2,3-d)pyrimidine and pyrimido(4,5-d)pyrimidine nucleosides
US20060003951A1 (en) Anti-viral 7-deaza L-nucleosides
US5597831A (en) 6-[X-(2-hydroxyethyl) aminoalkyl]-5,11-dioxo-5,6-dihydro-11-H-indeno[1,2-c]isoquinolines and their use as antineoplastic agents
US5591842A (en) Indolopyrrolocarbazole derivatives
FI63946C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 5'deoxi-5-fluorcytidin och 5'-deoxi-5-fluoruridin
HU201773B (en) Process for producing rebeccamycin analogs and pharmaceutical compositions comprising such active ingredient
US5668271A (en) Indolopyrrolocarbazole derivatives
US5589365A (en) Process for producing glycosylated indolopyrrolocarbazole derivatives by culturing certain microorganisms
AU663729B2 (en) 6((2-hydroxyethyl)aminoalkyl)-5,11-dioxo-5,6-dihydro-11-H- indeno-(1,2-C)isoquinoline and their use as antineoplastic agents
WO2000064918A1 (en) METHOD FOR THE PRODUCTION OF 2-CHLORO-2'-DEOXYADENOSINE (CLADRIBINE) AND ITS 3,5-DI-O-p-TOLUOYL DERIVATIVE
MXPA97002927A (es) L-piranosilnucleosidos
US20020052491A1 (en) Method for the production of 2-chloro-2' -deoxyadenosine (cladribine) and its 3,5-di-O-p-toluoyl derivative
KR870001935B1 (ko) 항포진성을 갖는 뉴클레오시 유도체 및 그의 산부가염의 제조방법
Kazimierczuk et al. Studies on Improved Synthesis of 2'-Deoxyribonucleosides of Pyridazine Derivatives
GB2287463A (en) Bis-anthracycline derivatives
PL172609B1 (en) Method of obtaining derivatives of indolopyrrolocarbasole
PL172316B1 (en) Method of obtaining novel derivatives of indolopyrrole carbazole
CA2203674A1 (en) L-pyranosyl nucleosides
NZ237941A (en) Mitomycin derivatives and pharmaceutical compositions thereof.